Pure Bioscience Inc
PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. Its technology platform contains silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. The comp… Read more
Market Cap & Net Worth: Pure Bioscience Inc (PURE)
Pure Bioscience Inc (PINK:PURE) has a market capitalization of $8.39 Million ($8.39 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #31320 globally and #10306 in its home market, demonstrating a -16.67% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Pure Bioscience Inc's stock price $0.08 by its total outstanding shares 111856000 (111.86 Million).
Pure Bioscience Inc Market Cap History: 2015 to 2025
Pure Bioscience Inc's market capitalization history from 2015 to 2025. Data shows change from $107.38 Million to $8.39 Million (-21.25% CAGR).
Pure Bioscience Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Pure Bioscience Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
5.13x
Pure Bioscience Inc's market cap is 5.13 times its annual revenue
0.11x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $107.38 Million | $729.00K | -$7.61 Million | 147.30x | N/A |
| 2016 | $97.54 Million | $1.29 Million | -$21.68 Million | 75.67x | N/A |
| 2017 | $105.70 Million | $1.83 Million | -$6.52 Million | 57.73x | N/A |
| 2018 | $42.51 Million | $1.77 Million | -$7.47 Million | 23.96x | N/A |
| 2019 | $32.44 Million | $1.91 Million | -$6.56 Million | 16.99x | N/A |
| 2020 | $87.25 Million | $6.92 Million | -$6.00K | 12.61x | N/A |
| 2021 | $21.25 Million | $3.93 Million | -$2.32 Million | 5.41x | N/A |
| 2022 | $8.95 Million | $1.85 Million | -$3.50 Million | 4.83x | N/A |
| 2023 | $14.54 Million | $1.88 Million | -$3.96 Million | 7.75x | N/A |
| 2024 | $10.07 Million | $1.96 Million | -$3.35 Million | 5.13x | N/A |
Competitor Companies of PURE by Market Capitalization
Companies near Pure Bioscience Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Pure Bioscience Inc by market ranking:
- Procter & Gamble Company (NYSE:PG): Ranked #35 globally with a market cap of $351.41 Billion USD.
- Unilever PLC (PINK:UNLYF): Ranked #141 globally with a market cap of $131.81 Billion USD.
- UNILEVER PLC LS -,035 (XETRA:UNV0): Ranked #147 globally with a market cap of $126.11 Billion USD ( €122.86 Billion EUR).
- L'Oréal S.A (PINK:LRLCF): Ranked #215 globally with a market cap of $94.58 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #35 | Procter & Gamble Company | NYSE:PG | $351.41 Billion | $151.48 |
| #141 | Unilever PLC | PINK:UNLYF | $131.81 Billion | $60.96 |
| #147 | UNILEVER PLC LS -,035 | XETRA:UNV0 | $126.11 Billion | €56.81 |
| #215 | L'Oréal S.A | PINK:LRLCF | $94.58 Billion | $368.10 |
Pure Bioscience Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Pure Bioscience Inc's market cap moved from $107.38 Million to $ 8.39 Million, with a yearly change of -21.25%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $8.39 Million | -16.67% |
| 2024 | $10.07 Million | -30.77% |
| 2023 | $14.54 Million | +62.50% |
| 2022 | $8.95 Million | -57.89% |
| 2021 | $21.25 Million | -75.64% |
| 2020 | $87.25 Million | +168.97% |
| 2019 | $32.44 Million | -23.68% |
| 2018 | $42.51 Million | -59.79% |
| 2017 | $105.70 Million | +8.37% |
| 2016 | $97.54 Million | -9.17% |
| 2015 | $107.38 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Pure Bioscience Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $8.39 Million USD |
| MoneyControl | $8.39 Million USD |
| MarketWatch | $8.39 Million USD |
| marketcap.company | $8.39 Million USD |
| Reuters | $8.39 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.